Assouline S, Culjkovic-Kraljacic B, Bergeron J, Caplan S, Cocolakis E, Lambert C, Lau CJ, Zahreddine HA, Miller WH, Borden KLB. A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E. Haematologica [Internet]. 2014Dec.31 [cited 2026Nov.6];100(1):e7-e9. Available from: https://haematologica.org/article/view/7269